As Courts Ban Online Sale Of Medicines, What Will Be The Impact On Consumers?
In successive weeks, the Madras and Delhi High Courts have banned the online sale of medicines, until the Centre notifies rules, throwing e-pharmacies into uncertainty. But where does that leave consumers?
DG Shah, secretary general of the Indian Pharmaceutical Alliance, pointed to the necessity for user data protection, which according to him, is a big challenge for online pharmacies.
“Compiling data in offline stores is a cumbersome process but in an online model, that process becomes much easier,” Shah said in an interview with BloombergQuint. “However, ensuring the security of user data is of paramount importance.”
E-pharmacy players must ensure the authenticity of prescriptions uploaded and that the right drugs are sold to customers.DG Shah, Secretary General, Indian Pharmaceutical Alliance
And then there are the discounts offered by online players, that has drawn consumers to them.
There is a margin of around 30 percent between the wholesaler and retailer, said Shah, which the manufacturer provides. “Out of this 30 percent, e-pharmacies are willing to part with 15 percent and offer a discount.” This, he said, would hurt offline payers.
KK Selvan, general secretary of Tamil Nadu Chemists and Druggists Association, said that online pharmacies don't pose any threat to offline stores. He said that chemists will be the biggest online player in India once the government formulates rules. “Currently, India does not have a law governing online pharmacies, either for uploading prescriptions or selling medicines.”
We have to welcome modernisation but we shouldn't violate any laws.KK Selven, General Secretary Of Tamil Nadu Chemists and Druggists Association
But online players say they are compliant with existing laws like the IT Act and Drugs and Cosmetics Act, seeking clarity from the government. “The pharma market is big enough for both online and offline players to sustain,” said Dharmil Sheth, co-founder of PharmEasy. Uncertainty, he said, is the biggest fear factor.
We are less than a percent of the industry. I don't think we are snatching away the business. It's more fear of the unknown.Dharmil Sheth, Co-Founder of PharmEasy
Watch the discussion here:
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.